EA199900755A1 - Производное хинолин-2-карбоновой кислоты и его применение в качестве антагониста возбуждающих аминокислот - Google Patents
Производное хинолин-2-карбоновой кислоты и его применение в качестве антагониста возбуждающих аминокислотInfo
- Publication number
- EA199900755A1 EA199900755A1 EA199900755A EA199900755A EA199900755A1 EA 199900755 A1 EA199900755 A1 EA 199900755A1 EA 199900755 A EA199900755 A EA 199900755A EA 199900755 A EA199900755 A EA 199900755A EA 199900755 A1 EA199900755 A1 EA 199900755A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antagonist
- amino acids
- application
- excessing
- quinolin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
| PCT/EP1998/001700 WO1998042673A1 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA199900755A1 true EA199900755A1 (ru) | 2000-08-28 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA199900755A EA199900755A1 (ru) | 1997-03-26 | 1998-03-24 | Производное хинолин-2-карбоновой кислоты и его применение в качестве антагониста возбуждающих аминокислот |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (pt) |
| JP (1) | JP2001518901A (pt) |
| KR (1) | KR20010005567A (pt) |
| CN (1) | CN1257482A (pt) |
| AP (1) | AP9901659A0 (pt) |
| AU (1) | AU731394B2 (pt) |
| BR (1) | BR9808424A (pt) |
| CA (1) | CA2284710A1 (pt) |
| EA (1) | EA199900755A1 (pt) |
| GB (1) | GB9706294D0 (pt) |
| HU (1) | HUP0001661A3 (pt) |
| ID (1) | ID24306A (pt) |
| IL (1) | IL131919A0 (pt) |
| IS (1) | IS5186A (pt) |
| NO (1) | NO994679L (pt) |
| NZ (1) | NZ337793A (pt) |
| PL (1) | PL335865A1 (pt) |
| TR (1) | TR199902315T2 (pt) |
| WO (1) | WO1998042673A1 (pt) |
| YU (1) | YU47699A (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| DE10137487A1 (de) * | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| DE10306202A1 (de) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| JP4360891B2 (ja) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法 |
| ES2531621T3 (es) * | 2005-07-22 | 2015-03-18 | Mochida Pharmaceutical Co., Ltd. | Derivado de heterociclidenacetamida novedoso |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| CN110996948A (zh) | 2017-06-12 | 2020-04-10 | 格莱泰施有限责任公司 | 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| AP876A (en) * | 1995-09-29 | 2000-09-27 | Glaxo Wellcome Spa | Tetrahydroquinolines as NMDA antagonists. |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/hu unknown
- 1998-03-24 JP JP54323498A patent/JP2001518901A/ja active Pending
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 YU YU47699A patent/YU47699A/sh unknown
- 1998-03-24 ID IDW991108A patent/ID24306A/id unknown
- 1998-03-24 EA EA199900755A patent/EA199900755A1/ru unknown
- 1998-03-24 IL IL13191998A patent/IL131919A0/xx unknown
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/xx unknown
- 1998-03-24 CN CN98805302A patent/CN1257482A/zh active Pending
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/ko not_active Application Discontinuation
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/pt not_active IP Right Cessation
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 PL PL98335865A patent/PL335865A1/xx unknown
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/is unknown
- 1999-09-24 NO NO994679A patent/NO994679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2284710A1 (en) | 1998-10-01 |
| GB9706294D0 (en) | 1997-05-14 |
| AU7209498A (en) | 1998-10-20 |
| NO994679L (no) | 1999-11-24 |
| BR9808424A (pt) | 2000-05-23 |
| KR20010005567A (ko) | 2001-01-15 |
| AP9901659A0 (en) | 1999-09-30 |
| ID24306A (id) | 2000-07-13 |
| TR199902315T2 (xx) | 2000-05-22 |
| NZ337793A (en) | 2001-02-23 |
| HUP0001661A2 (hu) | 2000-09-28 |
| YU47699A (sh) | 2001-12-26 |
| CN1257482A (zh) | 2000-06-21 |
| IL131919A0 (en) | 2001-03-19 |
| AU731394B2 (en) | 2001-03-29 |
| NO994679D0 (no) | 1999-09-24 |
| WO1998042673A1 (en) | 1998-10-01 |
| HUP0001661A3 (en) | 2001-12-28 |
| JP2001518901A (ja) | 2001-10-16 |
| IS5186A (is) | 1999-09-17 |
| EP0971896A1 (en) | 2000-01-19 |
| PL335865A1 (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| EA200500169A1 (ru) | Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение | |
| EA199900021A1 (ru) | Бициклические гетероароматические соединения в качестве ингибиторов протеинтирозинкиназы | |
| EA199900559A1 (ru) | Замещенные, азотсодержащие гетероциклы в качестве ингибиторов протеинкиназы p38 | |
| EA199900494A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| EA200200262A1 (ru) | Пиперазиновые производные и их применение в качестве противовоспалительных агентов | |
| EA200300248A1 (ru) | Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции | |
| EA199900855A1 (ru) | Соль производного нафтиридинкарбоновой кислоты | |
| EP2308833A3 (en) | Cyclic protein tyrosine kinase inhibitors | |
| EA200400777A1 (ru) | Фармацевтические композиции соединения платины | |
| EA200001224A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| BR9810841A (pt) | Inibidores de metaloprotease alicìclicos | |
| IT8848441A0 (it) | Derivato di 4h-benzopiran-4-one o suo sale, procedimento per produrlo e composizione farmaceutica che lo contiene come ingrediente attivo | |
| EA200300381A1 (ru) | Нуклеиновые кислоты и полипептиды нового рецептора | |
| EA200001176A1 (ru) | Гетероциклические ингибиторы p38 | |
| ES2128735T3 (es) | Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas. | |
| BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
| EA200000378A1 (ru) | Усеченные по амино-концу мср-2 как антагонисты хемокинов | |
| EA199901013A1 (ru) | Гели пролонгированного действия | |
| GR900100326A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof | |
| EA199900755A1 (ru) | Производное хинолин-2-карбоновой кислоты и его применение в качестве антагониста возбуждающих аминокислот | |
| EA200000165A1 (ru) | Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos | |
| EA200200650A1 (ru) | Замещенные производные пиперазина в качестве ингибиторов мтр-протеина | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера |